Zobrazeno 1 - 10
of 546
pro vyhledávání: '"immune checkpoint (ICP)"'
Autor:
Lin, Yu‐Chuan1,2 (AUTHOR), Chen, Mei‐Chih1 (AUTHOR), Huang, Shi‐Wei1,3,4 (AUTHOR), Chen, Yeh5 (AUTHOR), Ho, Jennifer Hui‐Chun2,6,7,8 (AUTHOR), Lin, Fang‐Yu1 (AUTHOR), Tan, Xiao‐Tong1 (AUTHOR), Chiang, Hung‐Che2,9 (AUTHOR), Huang, Chiu‐Ching2,10 (AUTHOR), Tu, Chih‑Yen11,12 (AUTHOR), Cho, Der‐Yang1,3,13,14 (AUTHOR) dycho@tool.caaumed.org.tw, Chiu, Shao‐Chih1,2,3,13 (AUTHOR) 016178@tool.caaumed.org.tw
Publikováno v:
Advanced Science. 11/6/2024, Vol. 11 Issue 41, p1-17. 17p.
Autor:
Yu‐Chuan Lin, Mei‐Chih Chen, Shi‐Wei Huang, Yeh Chen, Jennifer Hui‐Chun Ho, Fang‐Yu Lin, Xiao‐Tong Tan, Hung‐Che Chiang, Chiu‐Ching Huang, Chih‑Yen Tu, Der‐Yang Cho, Shao‐Chih Chiu
Publikováno v:
Advanced Science, Vol 11, Iss 41, Pp n/a-n/a (2024)
Abstract Immunotherapy targeting immune checkpoints (ICPs), such as programmed death‐ligand‐1 (PD‐L1), is used as a treatment option for advanced or metastatic non‐small cell lung cancer (NSCLC). However, overall response rate to anti‐PD‐
Externí odkaz:
https://doaj.org/article/7864291b849244c5babdc5d7f746e0bd
Autor:
Katty Zeven, Timo W.M. De Groof, Hannelore Ceuppens, Robin Maximilian Awad, Thomas Ertveldt, Wout de Mey, Fien Meeus, Geert Raes, Karine Breckpot, Nick Devoogdt
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionT cell Ig and ITIM domain receptor (TIGIT) is a next-generation immune checkpoint predominantly expressed on activated T cells and NK cells, exhibiting an unfavorable prognostic association with various malignancies. Despite the emergence
Externí odkaz:
https://doaj.org/article/051a7b27d7524e158560ba763978542a
Publikováno v:
Journal of Kunming Medical University / Kunming Yike Daxue Xuebao. 2024, Issue 6, p57-68. 12p.
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Background: The prognostic roles of ferroptosis-related mRNAs (FG) and lncRNAs (FL) in pediatric acute myeloid leukemia (P-AML) patients remain unclear.Methods: RNA-seq and clinical data of P-AML patients were downloaded from the TARGET project. Cox
Externí odkaz:
https://doaj.org/article/994699892f9b408ea28ba76c7ba13446
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/4f4390777c0f4e7dafeb9f66281c5a86
Autor:
Demirkale, Zeynep Hızlı1,2,3, Alpkıray, Mehmet Fatih4, Engin, Ayşe1, Sönmez, Aybars Deniz1, Yücel, Esra3, Tamay, Zeynep3, Özdemir, Cevdet3,5, Deniz, Günnur1, Aktaş, Esin Çetin1 esinaktas@yahoo.com
Publikováno v:
Balkan Medical Journal. Sep2024, Vol. 41 Issue 5, p387-395. 9p.
Autor:
Sihan Luo1,2,3, Daiyue Wang1,2,3, Jiajie Chen1,2,3, Shaocheng Hong4, Yuanyuan Fang5, Lu Cao6, Liang Yong7 18356013908@126.com, Shengxiu Liu1,2,3 liushengxiu@ahmu.edu.cn
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 15, p5085-5100. 16p.
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/226d813acf7344eaa917698d568c8461
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe incidence of thyroid cancer (THCA) continues to increase in recent decades. Accumulating evidence showed that the unbalanced alternative splicing (AS) promotes the occurrence of cancers and leads to poor prognosis of patients. However,
Externí odkaz:
https://doaj.org/article/a3e3ff3d4c044cdfa8a980c7b7df84b7